Molecular and Cellular Neurobiology of Spreading Depolarization/Depression and Migraine: A Narrative Review
International Journal of Molecular Sciences · 17.10.2024 · 25 (20) · 11163
DOI: 10.3390/ijms252011163 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.10.2024. Verfasst von Eiji Kitamura und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Kitasato University School of Medicine, Sagamihara 252-0329, Japan. Hauptthemen laut MEDLINE: Cortical Spreading Depression, Migraine Disorders, Calcitonin Gene-Related Peptide. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Migraine is a prevalent neurological disorder, particularly among individuals aged 20–50 years, with significant social and economic impacts. Despite its high prevalence, the pathogenesis of migraine remains unclear. In this review, we provide a comprehensive overview of cortical spreading depolarization/depression (CSD) and its close association with migraine aura, focusing on its role in understanding migraine pathogenesis and therapeutic interventions. We discuss historical studies that have demonstrated the role of CSD in the visual phenomenon of migraine aura, along with modern imaging techniques confirming its propagation across the occipital cortex. Animal studies are examined to indicate that CSD is not exclusive to migraines; it also occurs in other neurological conditions. At the cellular level, we review how CSD is characterized by ionic changes and excitotoxicity, leading to neuronal and glial responses. We explore how CSD activates the trigeminal nervous system and upregulates the expression of calcitonin gene-related peptides (CGRP), thereby contributing to migraine pain. Factors such as genetics, obesity, and environmental conditions that influence the CSD threshold are discussed, suggesting potential therapeutic targets. Current treatments for migraine, including prophylactic agents and CGRP-targeting drugs, are evaluated in the context of their expected effects on suppressing CSD activity. Additionally, we highlight emerging therapies such as intranasal insulin-like growth factor 1 and vagus nerve stimulation, which have shown promise in reducing CSD susceptibility and frequency. By elucidating the molecular and cellular mechanisms of CSD, this review aims to enhance the understanding of migraine pathogenesis and support the development of targeted therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Kitasato University School of Medicine, Sagamihara 252-0329, Japan.
- Department of Neurology and Headache Center, Japanese Red Cross Shizuoka Hospital, Shizuoka 420-0853, Japan.
ORCID-Profile: Noboru Imai
Zitieren
APA
Kitamura, E., & Imai, N. (2024). Molecular and Cellular Neurobiology of Spreading Depolarization/Depression and Migraine: A Narrative Review. International Journal of Molecular Sciences, 25(20), 11163. https://doi.org/10.3390/ijms252011163
Vancouver
Kitamura E, Imai N. Molecular and Cellular Neurobiology of Spreading Depolarization/Depression and Migraine: A Narrative Review. International Journal of Molecular Sciences. 2024;25(20):11163. doi:10.3390/ijms252011163
BibTeX
@article{Kitamura2024,
author = {Kitamura, Eiji and Imai, Noboru},
title = {Molecular and Cellular Neurobiology of Spreading Depolarization/Depression and Migraine: A Narrative Review},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {20},
pages = {11163},
doi = {10.3390/ijms252011163}
}
EUVIMED